The potential therapeutic effect of sentinel lymphadenectomy

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Sentinel lymph node (SLN) biopsy in a minimally invasive staging procedure for early breast cancer patients that is currently being investigated in many institutional and multi-institutional studies. Its main perspectives are the omission of axillary dissection in sentinel lymph node-negative patients and an improved staging as a result of more intensive histopathological methods for the detection of nodal involvement. The hypothesis presented in this article suggests that sentinel lymphadenectomy may also serve as a therapeutic intervention in some patients. The background for this comes from historical studies before the general use of systemic adjuvant treatment, which suggest that some node-positive breast cancer patients seem to be curable by locoregional treatment alone. Recent studies show that many patients have nodal metastases limited to the SLNs, where (considering the sigmoid growth model of solid tumours) small metastases may grow faster than larger ones. Large metastases are associated with worse prognosis. It is suggested that, in consequence of its expected therapeutic effects, sentinel lymphadenectomy, i.e. the removal of the lymph nodes most likely to harbour metastases, should be preferred to the omission of axillary dissection, or any other surgical staging procedure based on predictive models of nodal involvement derived from primary tumour characteristics.

Original languageEnglish
Pages (from-to)689-691
Number of pages3
JournalEuropean Journal of Surgical Oncology
Volume28
Issue number7
DOIs
Publication statusPublished - Nov 2002

Fingerprint

Therapeutic Uses
Lymph Node Excision
Neoplasm Metastasis
Dissection
Breast Neoplasms
Sentinel Lymph Node Biopsy
Sigmoid Colon
Neoplasms
Therapeutics
Lymph Nodes
cyhalothrin
Growth

Keywords

  • Breast cancer
  • Locoregional treatment
  • Sentinel lymph node

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

The potential therapeutic effect of sentinel lymphadenectomy. / Cserni, G.

In: European Journal of Surgical Oncology, Vol. 28, No. 7, 11.2002, p. 689-691.

Research output: Contribution to journalArticle

@article{f3434c58011e42be91776a2228f06794,
title = "The potential therapeutic effect of sentinel lymphadenectomy",
abstract = "Sentinel lymph node (SLN) biopsy in a minimally invasive staging procedure for early breast cancer patients that is currently being investigated in many institutional and multi-institutional studies. Its main perspectives are the omission of axillary dissection in sentinel lymph node-negative patients and an improved staging as a result of more intensive histopathological methods for the detection of nodal involvement. The hypothesis presented in this article suggests that sentinel lymphadenectomy may also serve as a therapeutic intervention in some patients. The background for this comes from historical studies before the general use of systemic adjuvant treatment, which suggest that some node-positive breast cancer patients seem to be curable by locoregional treatment alone. Recent studies show that many patients have nodal metastases limited to the SLNs, where (considering the sigmoid growth model of solid tumours) small metastases may grow faster than larger ones. Large metastases are associated with worse prognosis. It is suggested that, in consequence of its expected therapeutic effects, sentinel lymphadenectomy, i.e. the removal of the lymph nodes most likely to harbour metastases, should be preferred to the omission of axillary dissection, or any other surgical staging procedure based on predictive models of nodal involvement derived from primary tumour characteristics.",
keywords = "Breast cancer, Locoregional treatment, Sentinel lymph node",
author = "G. Cserni",
year = "2002",
month = "11",
doi = "10.1053/ejso.2002.1332",
language = "English",
volume = "28",
pages = "689--691",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - The potential therapeutic effect of sentinel lymphadenectomy

AU - Cserni, G.

PY - 2002/11

Y1 - 2002/11

N2 - Sentinel lymph node (SLN) biopsy in a minimally invasive staging procedure for early breast cancer patients that is currently being investigated in many institutional and multi-institutional studies. Its main perspectives are the omission of axillary dissection in sentinel lymph node-negative patients and an improved staging as a result of more intensive histopathological methods for the detection of nodal involvement. The hypothesis presented in this article suggests that sentinel lymphadenectomy may also serve as a therapeutic intervention in some patients. The background for this comes from historical studies before the general use of systemic adjuvant treatment, which suggest that some node-positive breast cancer patients seem to be curable by locoregional treatment alone. Recent studies show that many patients have nodal metastases limited to the SLNs, where (considering the sigmoid growth model of solid tumours) small metastases may grow faster than larger ones. Large metastases are associated with worse prognosis. It is suggested that, in consequence of its expected therapeutic effects, sentinel lymphadenectomy, i.e. the removal of the lymph nodes most likely to harbour metastases, should be preferred to the omission of axillary dissection, or any other surgical staging procedure based on predictive models of nodal involvement derived from primary tumour characteristics.

AB - Sentinel lymph node (SLN) biopsy in a minimally invasive staging procedure for early breast cancer patients that is currently being investigated in many institutional and multi-institutional studies. Its main perspectives are the omission of axillary dissection in sentinel lymph node-negative patients and an improved staging as a result of more intensive histopathological methods for the detection of nodal involvement. The hypothesis presented in this article suggests that sentinel lymphadenectomy may also serve as a therapeutic intervention in some patients. The background for this comes from historical studies before the general use of systemic adjuvant treatment, which suggest that some node-positive breast cancer patients seem to be curable by locoregional treatment alone. Recent studies show that many patients have nodal metastases limited to the SLNs, where (considering the sigmoid growth model of solid tumours) small metastases may grow faster than larger ones. Large metastases are associated with worse prognosis. It is suggested that, in consequence of its expected therapeutic effects, sentinel lymphadenectomy, i.e. the removal of the lymph nodes most likely to harbour metastases, should be preferred to the omission of axillary dissection, or any other surgical staging procedure based on predictive models of nodal involvement derived from primary tumour characteristics.

KW - Breast cancer

KW - Locoregional treatment

KW - Sentinel lymph node

UR - http://www.scopus.com/inward/record.url?scp=0036881111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036881111&partnerID=8YFLogxK

U2 - 10.1053/ejso.2002.1332

DO - 10.1053/ejso.2002.1332

M3 - Article

C2 - 12431463

AN - SCOPUS:0036881111

VL - 28

SP - 689

EP - 691

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 7

ER -